These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4366516)

  • 21. [Ulcero-necrotic purpura revealing Kahler's disease, with macroglobulinemia].
    Bureau Y; Barrière H; Senelar R; Litoux P; Bureau B
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):495-8. PubMed ID: 4967360
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognosis of myelomatosis on treatment with prednisone and cytostatics.
    Hansen OP; Jessen B; Videbaek A
    Scand J Haematol; 1973; 10(4):282-90. PubMed ID: 4764610
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug therapy in hemoblastosis].
    Bischof B
    Folia Clin Int (Barc); 1968 Jun; 18(6):365-8. PubMed ID: 4988909
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple myeloma. II. The value of melphalan.
    Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
    S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapy of macroglobulinaemia. Comparison of the effect of therapy on the level of monoclonal immunoglobulins and on clinical symptoms in four cases of waldenström's macroglobulinaemia and one case of IgA myeloma.
    Pronk EA; Elkerbout F; Klein F; Radema H; Cleton FJ
    Acta Med Scand; 1969 Oct; 186(4):273-81. PubMed ID: 4190857
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modern hematology. Sidero-achrestic anemias, polyglobulias, chemotherapy].
    Clément F
    Schweiz Med Wochenschr; 1971 Feb; 101(6):194-9. PubMed ID: 4998156
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma.
    Pavlovsky S; Saslavsky J; Tezanos Pinto M; Palmer L; Curuchet M; Lein JM; Garay G; Dragosky M; Quiroga-Micheo E; Huberman AB
    J Clin Oncol; 1984 Jul; 2(7):836-40. PubMed ID: 6376722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chemotherapy of plasma cell myeloma and related disorders.
    Coleman M; Silver RT
    Antibiot Chemother (1971); 1974; 18():112-47. PubMed ID: 4219116
    [No Abstract]   [Full Text] [Related]  

  • 29. Vindesine in refractory multiple myeloma.
    van der Lelie H; Monasch E; Pegels HG; von dem Borne AE
    Cancer; 1986 Jan; 57(2):226-9. PubMed ID: 3942957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myelomatosis].
    Bjerve KS; Sauar J; Stavem P; Skrede S
    Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2250-5. PubMed ID: 4216119
    [No Abstract]   [Full Text] [Related]  

  • 31. The contribution of immunoserologic investigations to diagnosis of autoimmune hemolytic anemias in patients with malignant hemopathies.
    Gologan R; Ursea C; Ciocoiu A; Berceanu S
    Med Interne; 1979; 17(3):293-9. PubMed ID: 116359
    [No Abstract]   [Full Text] [Related]  

  • 32. [Multiple myeloma and other plasma cell dyscrasias].
    del Potro Gómez E; Morales Sanz D
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():52-7. PubMed ID: 10422451
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of myeloma].
    Sonntag RW
    Dtsch Med Wochenschr; 1977 Sep; 102(36):1289-91. PubMed ID: 902591
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunosuppressive agents in hematology].
    Sanchez-Fayos J; Outeirino J; Serrano J; Calabuig MT; Paniagua G
    Minerva Med; 1970 Jul; 61(55):3082-98. PubMed ID: 4316809
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of multiple myeloma in patients with Gaucher disease.
    Machaczka M; Lerner R; Klimkowska M; Hägglund H
    Am J Hematol; 2009 Oct; 84(10):694-6. PubMed ID: 19743447
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination chemotherapy for multiple myeloma.
    Alexanian R; Bonnet J; Gehan E; Haut A; Hewlett J; Lane M; Monto R; Wilson H
    Cancer; 1972 Aug; 30(2):382-9. PubMed ID: 5051662
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs.
    Cardamone JM; Kimmerle RI; Marshall EY
    Am J Med; 1974 Nov; 57(5):836-42. PubMed ID: 4216270
    [No Abstract]   [Full Text] [Related]  

  • 38. Dose intensity analysis of melphalan and prednisone in multiple myeloma.
    Palmer M; Belch A; Hanson J; Brox L
    J Natl Cancer Inst; 1988 May; 80(6):414-8. PubMed ID: 3367382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using corticosteroids.
    Pittman JG
    Am Fam Physician; 1971 May; 3(5):96-100. PubMed ID: 4325070
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term survival of a patient with multiple myeloma--a cure? A case report.
    Dutcher JP; Wiernik PH
    Cancer; 1984 May; 53(10):2069-72. PubMed ID: 6704893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.